About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Microneedle Patch Vaccination with RSV Virus Effective against RSV

by Mohamed Fathima S on December 18, 2018 at 9:47 AM
Font : A-A+

Microneedle Patch Vaccination with RSV Virus Effective against RSV

Providing skin vaccination using a microneedle containing the inactivated respiratory syncytial virus (RSV) and a compound that stimulates immune responses to the virus proves to be protective against the infection caused by the virus. Exposure to the virus causes severe disease and inflammation in the body.

The findings, published in the journal PLOS ONE, describe a promising, effective RSV vaccine and delivery method, which was tested in mice. There are no approved vaccines to protect against this disease.

Advertisement


RSV is a common respiratory disease, but it can be serious for young children, patients with compromised immune systems and elderly people. For children under 1 year old in the United States, RSV is the most common cause of bronchiolitis, inflammation of the small airways in the lung and pneumonia, infection of the lungs.

Each year in the U.S., the disease is responsible for 57,527 hospitalizations among children younger than 5 years old, 177,000 hospitalizations among adults older than 65 years old and 14,000 deaths among adults older than 65 years old, according to the Centers for Disease Control and Prevention. There is no licensed vaccine for RSV. In the 1960s, a formalin-inactivated respiratory syncytial virus (FI-RSV) vaccine, delivered intramuscularly (injected into muscle) and tested in clinical trials, had the opposite desired effect and enhanced the disease in children after they were exposed to the virus.
Advertisement

In this study, the researchers tested microneedle patch delivery of the FI-RSV vaccine with and without an adjuvant, a substance that enhances the body's immune response to foreign particles, called monophosphoryl lipid A. To compare efficacy to the microneedle patch, they also delivered the FI-RSV vaccine intramuscularly. The studies were conducted in mice. The microneedle patch was developed by Dr. Mark Prausnitz of the Georgia Institute of Technology.

Microneedle patches contain small needles measuring one millionth of a meter that are coated with vaccines in dry formulation. They can be applied to the skin as a patch and administered simply and painlessly. This technique of delivering vaccines to the skin could be ideal for children who are afraid of needles and more effective in preventing RSV vaccine-enhanced disease. Studies have found that microneedle patch vaccination can result in stronger, wider and longer-lasting immune responses than intramuscular vaccination. The addition of the adjuvant to the microneedle patch significantly increased the vaccine's ability to induce an immune response, clear the virus from the lungs of mice and prevent RSV inflammatory disease.



Source: Eurekalert
Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Microneedle Patch Vaccination with RSV Virus Effective against RSV Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests